In vivo activation of invariant Vα14 natural killer T cells by α-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity

European Journal of Immunology

Volumn 34, Issue 5, 2004, Pages 1381-1388

  Lisbonne, Mariette ^a   Hachem, Patricia ^a   Tonanny, Marie Béatrice ^a   Fourneau, Jean Marie ^a   Sidobre, Stephane ^b   Kronenberg, Mitchel ^b   Van Endert, Peter ^a   Dy, Michel ^a   Schneider, Elke ^a   Leite de Moraes, Maria C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD1d; Cytotoxicity; IFN ; NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MONOCLONAL ANTIBODY; ANTIBODY; FAS PROTEIN, MOUSE; FASL PROTEIN, MOUSE; GALACTOSYLCERAMIDE; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; NEUROPEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; GENETIC TRANSFECTION; IN VIVO STUDY; INJECTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TARGET CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIGENS, CD95; FAS LIGAND PROTEIN; GALACTOSYLCERAMIDES; INTERFERON TYPE II; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICE; NEUROPEPTIDES; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; UP-REGULATION;

EID: 4544236021     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324828     Document Type: Article

References (30)

1. Kronenberg, M. and Gapin, L., The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002. 2: 557-568.
2. Lisbonne, M. and Leite-de-Moraes, M. C., Invariant Vα14 NKT lymphocytes: a double-edged immuno-regulatory T cell population. Eur Cytokine Netw. 2003. 14: 4-14.
3. Bendelac, A., Positive selection of mouse NK1 + T cells by CD1- expressing cortical thymocytes. J. Exp. Med. 1995. 182: 2091-2096.
4. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M., CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626–1629.
5. Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M. and Chapman, P. B., Cross-presentation of disialoganglioside GD3 to natural killer T cells, J. Exp. Med. 2003. 198: 171-181.
6. Hansen, D. S., Siomos, M. A., Buckingham, L., Scalzo, A. A. and Schofield, L., Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 2003, 18: 391-402.
7. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-de-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J. F. and Herbelin, A., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autommune type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
8. Mars, L. T., Laloux, V., Goude, K., Desbois, S., Saoudi, A., Van Kaer, L., Lassmann, H., Herbelin, A., Lehuen, A. and Liblau, R. S., Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 2002. 168: 6007-6011.
9. Lisbonne, M., Diem, S., Castro-Keller, A., Lefort, J., Araujo, L. M., Hachem, P., Fourneau, J.-M., Sidolbre, S., Kronenberg, M., Taniguchi, M., Van Endert, P., Dy, M., Askenase, P., Russo, M., Vargaftig, B. B., Herbelin, A. and Leite-de-Moraes, M. C., Cutting edge: invariant Vα14 NKT cells are required for allergen- induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 2003. 171: 1637-1641.
10. Campos, R. A., Szczepanik, M., Itakura, A., Akahira-Azuma, M., Sidobre, S., Kronenberg, M. and Askenase, P. W., Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 2003. 198: 785-796.
11. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y. and Taniguchi, M., Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA 1998. 95: 5690-5693.
12. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L., The natural killer T cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
13. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001. 413: 531-534.
14. Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H. and Godfrey, D. I., Sequential production of interferon-gamma by NK1.1 (+) T cells and natural killer cells is essential for the antimetastatic effect of alpha- galactosylceramide. Blood 2002. 99: 1259–1266.
15. Leite-de-Moraes, M. C., Lisbonne, M., Arnould, A., Machavoine, F., Herbelin, A., Dy, M. and Schneider, E., Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment. Eur. J. Immunol. 2002. 32: 1897-1904.
16. Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y. and Bendelac, A., Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999. 163: 4647-4650.
17. Leite-de-Moraes, M. C., Herbelin, A., Gouarin, C., Koezuka, Y., Schneider, E. and Dy, M., Fas/Fas ligand interactions promote activation-induced cell death of NKT lymphocytes. J. Immunol. 2000. 165: 4367-4371.
18. Wilson, M. T., Johansson, C., Olivares-Villagomez, D., Singh, A. K., Stanic, A. K., Wang, C. R., Joyeux, I., Wick, M. J. and Van Kaer, L., The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 2003. 100: 10913-10918.
19. Crowe, N. Y., Uldrich, A. P., Kyparissoudis, K., Hammond, K. J. L., Hayakawa, Y., Sidobre, S., Keating, R., Kronenberg, M., Smyth, M. J. and Godfrey, D., Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells. J. Immunol. 2003. 171: 4020-4027.
20. Eberl, G. and MacDonald, H. R., Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 2000. 30:985–992.
21. Leite-de-Moraes, M. C., Hameg, A., Arnould, A., Machavoine, F., Koezuka, Y., Schneider, E., Herbelin, A. and Dy, M., A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J. Immunol. 1999. 163: 5871–5876.
22. Nakagawa, R., Nagafune, I., Tazunoki, Y., Ehara, H., Tomura, H., Iijima, R., Motoki, K., Kamishohara, M. and Saki, S., Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J. Immunol. 2001. 166: 6578-6584.
23. Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H. and Okumura, K., Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 2000. 97: 5498-5503.
24. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 1995. 373: 385-386.
25. Lee, H. O. and Ferguson, T. A., Biology of FasL. Cytokine Growth Factor Rev. 2003. 14: 325-335.
26. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195:625– 636.
27. Hayakawa, Y., Takeda, K., Yagita, H., Smyth, M. J., Van Kaer, L., Okumura, K. and Saiki, I., IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha- galactosylceramide. Blood 2002. 100: 1728-1733.
28. Morita, M., Motoki, K., Alkimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E. and Fukushima, H., Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J. Med. Chem. 1995. 38: 2176-2187.
29. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
30. Matzinger, P., The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 1991. 145: 185-192.